Intravenous Thrombolysis and NOAC
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 280 participants.
Also called NCT06749834
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 280 participants
- Registry
-
NCT06749834
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06749834. Randomized; double masking; primary purpose treatment. Start 2025-01-27 (actual); primary completion 2026-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intravenous Thrombolysis and NOAC
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- Intravenous thrombolysis
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
Record details
- Record id
cardio:ct-nct06749834- Content hash
5939001f188211544b284b0d56ebc3063ca1853e41eabdcc42b2d64d87400a5d